−4.9226 USD
−82.95 M USD
0.00 USD
18.20 M
About NKGen Biotech, Inc.
Sector
Industry
CEO
Paul Y. Song
Website
Headquarters
Santa Ana
Founded
2017
FIGI
BBG00ZFCTT22
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NKGN is 0.5210 USD — it has increased by 1.24% in the past 24 hours. Watch NKGen Biotech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NKGen Biotech, Inc. stocks are traded under the ticker NKGN.
NKGN stock has fallen by −8.26% compared to the previous week, the month change is a 90.11% rise, over the last year NKGen Biotech, Inc. has showed a −84.59% decrease.
NKGN reached its all-time high on Sep 19, 2023 with the price of 12.8800 USD, and its all-time low was 0.2026 USD and was reached on Oct 15, 2024. View more price dynamics on NKGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NKGN stock is 14.17% volatile and has beta coefficient of −0.42. Track NKGen Biotech, Inc. stock price on the chart and check out the list of the most volatile stocks — is NKGen Biotech, Inc. there?
Today NKGen Biotech, Inc. has the market capitalization of 17.55 M, it has decreased by −0.34% over the last week.
Yes, you can track NKGen Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
NKGN net income for the last quarter is −16.09 M USD, while the quarter before that showed −5.38 M USD of net income which accounts for −198.92% change. Track more NKGen Biotech, Inc. financial stats to get the full picture.
No, NKGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 11, 2024, the company has 63.00 employees. See our rating of the largest employees — is NKGen Biotech, Inc. on this list?
Like other stocks, NKGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NKGen Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NKGen Biotech, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NKGen Biotech, Inc. stock shows the sell signal. See more of NKGen Biotech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.